Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
A blocking peptide from human OMG.
Synthetic
C-KVTKIPKQYRTKE The OMgp Blocking Peptide is derived from Synthetic. The OMgp Blocking Peptide has been validated for the following applications: Antibody Competition.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-045813 |
| Réf. fabricant | 18058203 |
| Gene ID (Entrez) | 4974 |
| Espèces | Human |
| Pureté | >50%, by HPLC |
| Numéro d’adhésion | NP_002535.3 |
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
| Formule | Lyophilized from a 5 pmol/ul solution in 5% (v/v) acetonitrile/H<sub>2</sub>O and TFA salt. |
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NB100-2557. For Further Blocking Peptide Related Protocol, Click Here . |
| Alias de gène | oligodendrocyte myelin glycoprotein, OMGPoligodendrocyte-myelin glycoprotein |
| Symbole de gène(s) | OMG |
| Type de produit | OMgp |
| Quantité | 0.1 mg |
| État réglementaire | RUO - research use only |
| Catégorie de recherche | Neuroscience |
